Experimental and clinical background

Validation in experimental studies

In vitro and in vivo experimental studies have shown a pathophysiological role of ApoJ-Glyc in ischemic disease.

Link to publication


Early decrease in ApoJ-Glyc circulating levels upon ischemia induction


Intracellular accumulation of ApoJ-Glyc upon ischemia induction


Progressive decrease of ApoJ-Glyc release with ischemia

Our studies have demonstrated for the first time the association between decreased ApoJ-Glyc levels and ischemia induced changes in cardiac cells

Let's get in touch